Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Grujovic

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Plos One|August 21, 2019
Targeted transcript quantification in single disseminated cancer cells after whole transcriptome amplificationFranziska C Durst, Ana Grujovic, Iris Ganser, et al.
Nature Communications|October 6, 2020
Interleukin-6 trans-signaling is a candidate mechanism to drive progression of human DCCs during clinical latencyMelanie Werner-Klein, Ana Grujovic, Christoph Irlbeck, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Plos One|August 21, 2019
Targeted transcript quantification in single disseminated cancer cells after whole transcriptome amplificationFranziska C Durst, Ana Grujovic, Iris Ganser, et al.
Nature Communications|October 6, 2020
Interleukin-6 trans-signaling is a candidate mechanism to drive progression of human DCCs during clinical latencyMelanie Werner-Klein, Ana Grujovic, Christoph Irlbeck, et al.
Pageof 1